C. I. Bautista-Hernández et al. / Tetrahedron: Asymmetry xxx (2016) xxx–xxx
15
(1H, td, J = 7.6, 1.0 Hz, H5), 6.86 (1H, dd, J = 8.0, 1.0 Hz, H7), 6.28
(1H, br t, J = 5.3 Hz, H10), 3.23 (3H, s, NMe), 3.15 (1H, ddd,
J = 13.3, 8.1, 5.9 Hz, H11A), 3.07 (1H, ddd, J = 13.3, 7.6, 5.7 Hz,
H11B), 2.80, 2.64 (2H, AB system, J = 14.5 Hz, H8), 2.29 (1H, m,
H18A), 2.00 (1H, m, H12), 1.93–1.80 (4H, overlapped, H15, H16,
H17e), 1.65 (1H, m, H13); 1.43 (3H, s, C3-Me), 1.36 (1H, m,
H17a), 1.09 (3H, s, H20), 0.95 (3H, s, H19), 0.82 (1H, d, J = 9.5 Hz,
H18B). 13C NMR (100 MHz, CDCl3): d 180.7 (C2), 168.9 (C9),
142.6 (C7a), 133.1 (C3a), 128.1 (C6), 123.0 (C5), 122.9 (C4), 108.3
(C7), 46.4 (C3), 45.0 (C11), 43.8 (C8), 43.4 (C13), 41.3 (C15), 41.2
(C12), 38.5 (C14), 33.2 (C18), 27.9 (C20), 26.4 (NMe), 25.9 (C16),
23.8 (C3-Me), 23.0 (C19), 19.8 (C17). IR (film) mmax 3317, 2924,
2868, 1705, 1651, 1550 cmꢀ1. EIMS m/z (relative intensity) 354
([M]+, 5), 218 (28), 174 (100), 160 (43), 146 (17). HRMS (ESI) m/z
calcd for C22H31N2O2 [M+H]+: 355.2380. Found: 355.2386.
7.82–7.79 (2H, overlapped, H16, H19), 7.74 (1H, m, H15), 7.44
(1H, ddd, J = 8.0, 6.8, 1.0 Hz, H17), 7.41–7.39 (2H, overlapped,
H13, H14), 7.33 (1H, ddd, J = 8.4, 6.8, 1.3 Hz, H18), 7.21 (1H, td,
J = 7.7, 1.3 Hz, H6), 7.20 (1H, m, H4), 7.04 (1H, td, J = 7.5, 1.0 Hz,
H5), 6.56 (1H, d, J = 7.6 Hz, H7), 6.29 (1H, br d, J = 8.8 Hz, H10),
5.71 (1H, dq, J = 8.7, 6.8 Hz, H11), 2.78, 2.58 (2H, AB system,
J = 14.0 Hz, H8), 2.74 (3H, s, NMe), 1.87 (1H, dq, J = 13.7, 7.4 Hz,
CH2CH3A), 1.77 (1H, dq, J = 13.5, 7.4 Hz, CH2CH3B), 1.42 (3H, d,
J = 6.8 Hz, H20), 0.53 (3H, t, J = 7.4 Hz, CH2CH3). 13C NMR
(100 MHz, CDCl3): d 179.9 (C2), 167.9 (C9), 143.8 (C7a), 138.5
(C12), 134.0 (C15a), 131.3 (C19a), 130.8 (C3a), 128.8 (C16), 128.4
(C15, C6), 126.9 (C18), 126.0 (C17), 125.4 (C14), 123.7 (C19),
123.4 (C4), 122.9 (C5), 122.7 (C13), 108.4 (C7), 51.8 (C3), 44.1
(C11), 43.7 (C8), 31.3 (CH2CH3), 25.9 (NMe), 20.7 (C20), 8.4 (CH2-
CH3). IR (KBr) mmax 3292, 3051, 2971, 2936, 1709, 1655, 1609,
1547 cmꢀ1. EIMS m/z (relative intensity) 386 ([M]+, 14), 188 (15),
170 (100), 146 (15). Anal. Calcd for C25H26N2O2: C, 77.69; H,
6.78; N, 7.25. Found: C, 77.73; H, 6.94; N, 6.80.
4.4.13. 2-((R)-1-Ethyl-3-methyl-2-oxoindolin-3-yl)-N-((R)-1-
(naphthalen-1-yl)ethyl)acetamide (3R)-2l
Prepared from 9a (iii) as a white solid (0.193 g, 47%), mp: 159–
161 °C. ½a 2D0
ꢂ
= +62.0 (c 1.0, CHCl3). 1H NMR (400 MHz, CDCl3): d
4.4.16. 2-((S)-3-Ethyl-1-methyl-2-oxoindolin-3-yl)-N-((R)-1-
(naphthalen-1-yl)ethyl)acetamide (3S)-2m
7.89 (1H, d, J = 8.5 Hz, H19), 7.81 (1H, m, H16), 7.75 (1H, m, H15),
7.45 (1H, ddd, J = 8.0, 6.9, 1.2 Hz, H17), 7.42–7.40 (2H, overlapped,
H13, H14), 7.39 (1H, ddd, J = 8.3, 6.8, 1.4 Hz, H18), 7.25 (1H, dd,
J = 7.4, 0.7 Hz, H4), 7.23 (1H, td, J = 7.7, 1.2 Hz, H6), 7.02 (1H, td,
J = 7.7, 1.0 Hz, H5), 6.69 (1H, d, J = 7.8 Hz, H7), 6.53 (1H, br d,
J = 8.6 Hz, H10), 5.77 (1H, dq, J = 8.5, 6.8 Hz, H11), 3.55 (1H, dq,
J = 14.5, 7.3 Hz, CH2CH3A), 3.31 (1H, dc, J = 14.3, 7.2 Hz, CH2CH3B),
2.76, 2.58 (2H, AB system, J = 14.3 Hz, H8), 1.46 (3H, d, J = 6.8 Hz,
H20), 1.39 (3H, s, C3-Me), 1.10 (3H, t, J = 7.2 Hz, CH2CH3). 13C NMR
(100 MHz, CDCl3): d 180.2 (C2), 168.0 (C9), 142.0 (C7a), 138.5
(C12), 134.0 (C15a), 133.4 (C3a), 131.3 (C19a), 128.8 (C16), 128.4,
128.3 (C15, C6), 126.8 (C18), 126.0 (C17), 125.4 (C14), 123.7 (C19),
123.4 (C4), 122.8 (C5, C13), 108.8 (C7), 46.6 (C3), 44.3 (C11), 44.1
(C8), 34.7 (CH2CH3), 24.2 (C3-Me), 20.8 (C20), 12.7 (CH2CH3). IR
(KBr) mmax 3271, 3049, 2980, 2963, 2940, 1702, 1650, 1608,
1538 cmꢀ1. EIME m/z (relative intensity) 386 ([M]+, 17), 188 (19),
170 (100), 155 (16), 128 (18). Anal. Calcd for C25H26N2O2: C,
77.69; H, 6.78; N, 7.25. Found: C, 77.19; H, 6.85; N, 6.96.
Prepared from 9b (i
v
) as a white solid (0.186 g, 45%), mp: 164–
166 °C. ½a 2D0
ꢂ
= +30.3 (c 1.0, CHCl3). 1H NMR (400 MHz, CDCl3): d
7.84–7.80 (2H, overlapped, H16, H19), 7.75 (1H, m, H15), 7.47
(1H, ddd, J = 8.1, 6.9, 1.2 Hz, H17), 7.43–7.38 (3H, overlapped,
H13, H14, H18), 7.29 (1H, td, J = 7.6, 1.3 Hz, H6), 7.15 (1H, ddd,
J = 7.5, 1.3, 0.5 Hz, H4), 7.06 (1H, td, J = 7.5, 0.9 Hz, H5), 6.81 (1H,
d, J = 7.8 Hz, H7), 6.30 (1H, br d, J = 8.3 Hz, H10), 5.67 (1H, dq,
J = 8.1, 6.8 Hz, H11), 3.21 (3H, s, NMe), 2.81, 2.61 (2H, AB system,
J = 14.6 Hz, H8), 1.83 (1H, dq, J = 13.6, 7.4 Hz, CH2CH3A), 1.74 (1H,
dq, J = 13.5, 7.4 Hz, CH2CH3B), 1.47 (3H, d, J = 6.8 Hz, H20), 0.53
(3H, t, J = 7.4 Hz, CH2CH3). 13C NMR (100 MHz, CDCl3): d 180.0
(C2), 167.9 (C9), 144.2 (C7a), 138.2 (C12), 134.0 (C15a), 131.3
(C19a, C3a), 128.9 (C16), 128.4 (C15, C6), 126.7 (C18), 126.0
(C17), 125.4 (C14), 123.7 (C19), 123.2 (C4), 122.9, 122.8 (C5,
C13), 108.3 (C7), 51.4 (C3), 44.6 (C11), 43.5 (C8), 31.2 (CH2CH3),
26.5 (NMe), 20.7 (C20), 8.4 (CH2CH3). IR (KBr) mmax 3269, 3051,
2971, 2932, 1703, 1650, 1545 cmꢀ1. EIMS m/z (relative intensity)
387 ([M+H]+, 21), 188 (12), 170 (100), 146 (17). Anal. Calcd for
4.4.14. 2-((S)-1-Ethyl-3-methyl-2-oxoindolin-3-yl)-N-((R)-1-
(naphthalen-1-yl)ethyl)acetamide (3S)-2l
C25H26N2O2: C, 77.69; H, 6.78; N, 7.25. Found: C, 77.63; H, 6.93;
N, 6.76.
Prepared from 9a (iii) as a white solid (0.186 g, 45%), mp: 152–
154 °C. ½a 2D0
ꢂ
= +13.3 (c 1.0, CHCl3). 1H NMR (400 MHz, CDCl3): d
4.5. VCD measurements
7.89 (1H, d, J = 8.3 Hz, H19), 7.83 (1H, dm, J = 8.2 Hz, H16), 7.76
(1H, dd, J = 7.0, 2.3 Hz, H15), 7.47 (1H, ddd, J = 8.0, 6.8, 1.2 Hz,
H17), 7.45–7.38 (3H, overlapped, H13, H14, H18), 7.27 (1H, td,
J = 7.7, 1.2 Hz, H6), 7.21 (1H, ddd, J = 7.4, 1.2, 0.4 Hz, H4), 7.04 (1H,
td, J = 7.5, 0.9 Hz, H5), 6.85 (1H, d, J = 7.8 Hz, H7), 6.55 (1H, br d,
J = 8.2 Hz, H10), 5.74 (1H, dq, J = 8.1, 6.8 Hz, H11), 3.84 (1H, dq,
J = 14.5, 7.3 Hz, CH2CH3A), 3.69 (1H, dq, J = 14.3, 7.2 Hz, CH2CH3B),
2.78, 2.62 (2H, AB system, J = 14.8 Hz, H8), 1.50 (3H, d, J = 6.8 Hz,
H20), 1.31 (3H, s, C3-Me), 1.27 (3H, t, J = 7.2 Hz, CH2CH3). 13C NMR
(100 MHz, CDCl3): d 180.3 (C2), 168.0 (C9), 142.2 (C7a), 138.4
(C12); 134.1 (C15a), 133.7 (C3a), 131.2 (C19a), 128.9 (C16), 128.4,
128.3 (C15, C6), 126.7 (C18), 126.0 (C17), 125.5 (C14), 123.7 (C19),
123.2 (C4), 122.8 (C5, C13), 108.7 (C7), 46.5 (C3), 44.6 (C11), 44.0
(C8), 35.0 (CH2CH3), 24.2 (C3-Me), 20.9 (C20), 12.9 (CH2CH3). IR
IR and VCD spectra were measured using a BioTools ChiralIR
spectrophotometer equipped with dual photoelastic modulation.
Samples of (3R)-2a–m and (3S)-2a–m were dissolved in 150 lL
of CDCl3, placed in a BaF2 cell with a path length of 100 lm and
data were acquired at a resolution of 4 cmꢀ1 over 6 h. Baseline cor-
rections were done by subtracting the spectra from the solvent.
The stability of the samples was monitored by 1H NMR immedi-
ately prior and after VCD measurements.
4.6. X-ray diffraction analyses
Data for (3R)-2f–h, (3S)-2i were acquired on an Agilent Tech-
nologies Gemini A CCD diffractometer using Mo K
a radiation
(KBr) mmax 3259, 3051, 2975, 2935, 1703, 1653, 1612, 1548 cmꢀ1
.
(k = 0.7073 Å). The structures were solved by direct methods using
the SHELXS-9712 program included in the WINGX v1.6 package.13
Structural refinements were carried out by full-matrix least
squares on F2. The non-hydrogen atoms were treated anisotropi-
cally, and the hydrogen atoms, included in the structure factor cal-
culation, were refined isotropically. Atomic coordinates, bond
lengths, bond angles, and anisotropic thermal parameters are in
deposit at the Cambridge Crystallographic Data Center. Table 3
summarizes the relevant data and the CCDC deposition numbers.
EIMS m/z (relative intensity) 387 ([M+H]+, 25), 188 (16), 170
(100), 155 (17), 128 (22). Anal. Calcd for C25H26N2O2: C, 77.69; H,
6.78; N, 7.25. Found: C, 77.29; H, 6.89; N, 7.26.
4.4.15. 2-((R)-3-Ethyl-1-methyl-2-oxoindolin-3-yl)-N-((R)-1-
(naphthalen-1-yl)ethyl)acetamide (3R)-2m
Prepared from 9b (i
v
) as a white solid (0.182 g, 44%), mp: 212–
214 °C. ½a 2D0
ꢂ
= +62.8 (c 1.0, CHCl3). 1H NMR (400 MHz, CDCl3): d